MXPA04011990A - Composiciones farmaceuticas estabilizadas en la base de aceite de ricino polioxietilado y metodo para fabricar el mismo. - Google Patents

Composiciones farmaceuticas estabilizadas en la base de aceite de ricino polioxietilado y metodo para fabricar el mismo.

Info

Publication number
MXPA04011990A
MXPA04011990A MXPA04011990A MXPA04011990A MXPA04011990A MX PA04011990 A MXPA04011990 A MX PA04011990A MX PA04011990 A MXPA04011990 A MX PA04011990A MX PA04011990 A MXPA04011990 A MX PA04011990A MX PA04011990 A MXPA04011990 A MX PA04011990A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
stabilised
basis
manufacturing
same
Prior art date
Application number
MXPA04011990A
Other languages
English (en)
Inventor
Cirkva Ales
Original Assignee
Pliva Lachema As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Lachema As filed Critical Pliva Lachema As
Publication of MXPA04011990A publication Critical patent/MXPA04011990A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

La invencion se relaciona a una composicion farmaceutica estabilizada que comprende una sustancia farmaceuticamente activa pobremente soluble en agua, un agente de solubilizacion con un bajo contenido de compuestos acidicos y basicos, y un solvente organico polar, en particular, un concentrado de inyeccion estabilizado, metodos para preparar tales composiciones farmaceuticas estabilizadas y el uso de un agente de solubilizacion con un bajo contenido de compuestos acidicos y basicos para estabilizar composiciones farmaceuticas de sustancias farmaceuticamente activas.
MXPA04011990A 2002-06-10 2003-05-16 Composiciones farmaceuticas estabilizadas en la base de aceite de ricino polioxietilado y metodo para fabricar el mismo. MXPA04011990A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20022027A CZ294371B6 (cs) 2002-06-10 2002-06-10 Stabilizovaná farmaceutická kompozice na bázi polyoxyethylovaného ricinového oleje a způsob její přípravy
PCT/EP2003/005153 WO2003103714A1 (en) 2002-06-10 2003-05-16 Stabilised pharmaceutical compositions on the basis of polyoxyethylated castor oil and method for manufacturing the same

Publications (1)

Publication Number Publication Date
MXPA04011990A true MXPA04011990A (es) 2005-08-16

Family

ID=29721409

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04011990A MXPA04011990A (es) 2002-06-10 2003-05-16 Composiciones farmaceuticas estabilizadas en la base de aceite de ricino polioxietilado y metodo para fabricar el mismo.

Country Status (19)

Country Link
US (1) US20050142225A1 (es)
EP (1) EP1515751A1 (es)
JP (1) JP2005534656A (es)
KR (1) KR20050010030A (es)
CN (1) CN1655824A (es)
AU (1) AU2003240661A1 (es)
BR (1) BR0311687A (es)
CA (1) CA2487889A1 (es)
CZ (1) CZ294371B6 (es)
EA (1) EA007223B1 (es)
HR (1) HRP20041107A2 (es)
IL (2) IL165027A0 (es)
IS (1) IS7551A (es)
MX (1) MXPA04011990A (es)
NZ (1) NZ537150A (es)
PL (1) PL372071A1 (es)
RS (1) RS106704A (es)
WO (1) WO2003103714A1 (es)
ZA (1) ZA200408892B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005329255B2 (en) 2004-04-15 2010-09-30 Chiasma, Inc. Compositions capable of facilitating penetration across a biological barrier
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
AU2006212177A1 (en) * 2005-02-10 2006-08-17 Sindan Pharma Srl Method of purifying a surfactant by ultrafiltration
EP1690551A3 (en) * 2005-02-10 2006-10-18 Sindan Pharma Srl Method of purifying a surfactant by ultrafiltration
SA06270147B1 (ar) 2005-06-09 2009-12-22 نوفارتيس ايه جي عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
DE102008011691A1 (de) * 2008-02-28 2009-09-10 Schülke & Mayr GmbH Stabilisierte, antimikrobiell wirksame Zusammensetzung mit einem Gehalt an Bispyridiniumalkan
CN101596159B (zh) * 2008-06-03 2012-12-19 哈药集团生物工程有限公司 一种紫杉醇注射液及其制备方法
JP5623406B2 (ja) 2008-09-17 2014-11-12 キアズマ インコーポレイテッド 医薬組成物および関連する送達方法
MX2011005151A (es) * 2008-11-21 2011-05-30 Boehringer Ingelheim Int Composicion farmaceutica de un potente inhibidor de hvc para su administracion oral.
CA2767692C (en) 2009-07-07 2017-03-07 Boehringer Ingelheim International Gmbh Pharmaceutical composition for a hepatitis c viral protease inhibitor
CN101829051B (zh) * 2010-05-31 2012-09-12 南昌弘益科技有限公司 1’-乙酰氧基胡椒酚乙酸酯注射液
AU2016215350B2 (en) 2015-02-03 2021-11-25 Amryt Endo, Inc. Method of treating diseases
CN105497905A (zh) * 2015-12-30 2016-04-20 钟术光 一种供注射或口服用的辅料
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
CN112778513A (zh) * 2020-12-30 2021-05-11 江苏优仿医药科技有限公司 一种聚氧乙烯蓖麻油的精制方法及其应用
CN113281425B (zh) * 2021-04-15 2023-06-06 四川汇宇制药股份有限公司 一种聚氧乙烯(35)蓖麻油中游离脂肪酸的检测方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55108823A (en) * 1979-02-13 1980-08-21 Takemoto Oil & Fat Co Ltd Purification of alkylene oxide addition compound
US5112750A (en) * 1985-06-25 1992-05-12 Asama Chemical Co., Ltd. Immobilized cells and culture method utilizing the same
JPH02157274A (ja) * 1988-12-07 1990-06-18 Sumitomo Heavy Ind Ltd 植物油からビタミンｅを分離濃縮する方法
US6150398A (en) * 1991-05-08 2000-11-21 The United States Of America As Represented By The Department Of Health And Human Services Methods for the treatment of cancer
CA2086874E (en) * 1992-08-03 2000-01-04 Renzo Mauro Canetta Methods for administration of taxol
JP3020277B2 (ja) * 1992-09-22 2000-03-15 アメリカ合衆国 リンパ腫および乳癌を治療するためのタキソールの使用
KR100371062B1 (ko) * 1992-11-27 2003-04-21 에프.에이치.포울딩 앤드 컴퍼니 리미티드 안정성이향상된주사가능한택솔조성물및이를제형화하는방법
JP2880292B2 (ja) * 1992-11-27 1999-04-05 ナプロ バイオセラピューティクス，インコーポレイテッド 注射可能組成物
CA2092271C (en) * 1993-03-09 2009-10-13 Eddie Reed Use of g-csf for treating taxol side-effects
ES2290074T3 (es) * 1993-07-19 2008-02-16 Angiotech Pharmaceuticals, Inc. Composiciones anti-angiogenicas que contienen taxol y un vehiculo no biodegradable y su uso.
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
ATE201962T1 (de) * 1995-04-28 2001-06-15 Loders Croklaan Bv An polyungesättigten fettsäuren reiche triglyceride
DE19536165A1 (de) * 1995-09-28 1997-04-03 Basf Ag Verfahren zur Reinigung von alkoxylierten Fetten
US5925776A (en) * 1997-12-24 1999-07-20 Schein Pharmacetical, Inc. Polyethoxylated castor oil, process of making the same and formulations thereof
JP2000044840A (ja) * 1998-07-28 2000-02-15 Mitsubishi Heavy Ind Ltd 燃料ガス漏洩検知塗膜
CA2347097C (en) * 1998-10-20 2009-06-16 Ben Venue Laboratories, Inc. Process for purification of solvents useful in the preparation of pharmaceutical compositions
US6994834B1 (en) * 1999-09-22 2006-02-07 Nippon Aerosil Co., Ltd. Surface-modified fine silica powder and use thereof
JP2001247847A (ja) * 2000-03-03 2001-09-14 Nisshin Oil Mills Ltd:The 水性ゲル化剤
US7115565B2 (en) * 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability

Also Published As

Publication number Publication date
JP2005534656A (ja) 2005-11-17
EA007223B1 (ru) 2006-08-25
RS106704A (en) 2006-12-15
EA200401625A1 (ru) 2005-06-30
EP1515751A1 (en) 2005-03-23
CZ20022027A3 (cs) 2004-01-14
CN1655824A (zh) 2005-08-17
HRP20041107A2 (en) 2005-02-28
CA2487889A1 (en) 2003-12-18
IL165027A (en) 2009-12-24
CZ294371B6 (cs) 2004-12-15
IL165027A0 (en) 2005-12-18
BR0311687A (pt) 2008-01-15
PL372071A1 (en) 2005-07-11
US20050142225A1 (en) 2005-06-30
AU2003240661A1 (en) 2003-12-22
NZ537150A (en) 2006-09-29
WO2003103714A1 (en) 2003-12-18
ZA200408892B (en) 2006-01-25
IS7551A (is) 2004-11-25
KR20050010030A (ko) 2005-01-26

Similar Documents

Publication Publication Date Title
MXPA04011990A (es) Composiciones farmaceuticas estabilizadas en la base de aceite de ricino polioxietilado y metodo para fabricar el mismo.
WO2002008217A3 (en) COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS
WO2005041925A3 (en) Compositions and dosage forms for enhanced absorption
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
WO2007008752A3 (en) Sustained release pharmaceutical compositions for highly water soluble drugs
MX2008009357A (es) Una composicion solida de taxano liofilizada, un procedimiento para preparar dicha composicion solida, una formulacion farmaceuctica y un conjunto (kit) de dicha formulacion.
WO2002022598A8 (en) Quinolinone derivatives as tyrosine kinase inhibitors
MY142354A (en) Acidic insulin preparations having improved stability
WO2005112633A3 (en) Compounds and compositions for delivering active agents
MX2009003737A (es) Composicion inyectable en deposito y su procedimiento de preparacion.
WO2006044334A3 (en) Platelet-derived growth factor compositions and methods of use thereof
WO2008108286A1 (ja) 経皮吸収医薬組成物、医薬組成物貯蔵ユニットおよびこれを利用する経皮吸収製剤
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
TW200716202A (en) Pediatric formulation of topiramate
EA200301275A1 (ru) Капсулы для ингаляции
WO2009029958A3 (en) Implantable delivery device
WO2005009356A3 (en) Method for the preparation of controlled release formulations
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
WO2008143240A1 (ja) 特定の有機酸を含有する経口製剤並びに経口製剤の溶出性及び化学的安定性の改善方法
TW200616616A (en) Paclitaxel aqueous injection solution and methods for preparing the same
WO2005107467A3 (en) Compositions including opioids and methods of their use in treating pain
ATE424192T1 (de) Stabile pharmazeutische zubereitungen mit 2-aza- bicyclo 3.3.0 -octan-3-carboxylsäure-derivaten
WO2011076209A3 (en) Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue
WO2007124700A3 (en) Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof
IS8428A (is) Innrennslislyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn

Legal Events

Date Code Title Description
FA Abandonment or withdrawal